KKKoichi S. Kobayashi

Koichi S. Kobayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Koichi S. Kobayashi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Amlan Biswas

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02215, USA

    10 shared publications
  • Yuen-Joyce Liu

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute , Boston, MA 02215

    7 shared publications
  • Torsten B. Meissner

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute , Boston, MA 02215

    5 shared publications
  • Amy Li

    Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215

    4 shared publications
  • Kyoung-Hee Lee

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute , Boston, MA 02215

    3 shared publications
  • Tanja Petnicki-Ocwieja

    Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

    3 shared publications

Latest Publications

  • Cutting Edge: Impaired MHC Class I Expression in Mice Deficient for Nlrc5/Class I Transactivator

    by Amlan Biswas, Torsten B. Meissner, Taro Kawai, Koichi S. Kobayashi

    MHC class I and class II are crucial for the adaptive immune system. Although regulation of MHC class II expression by CIITA has long been recognized, the mechanism of MHC class I transactivation has been largely unknown until the recent discovery of NLRC5/class I transactivator. In this study, we show using Nlrc5-deficient mice that NLRC5 is required for both constitutive and inducible MHC class I expression. Loss of Nlrc5 resulted in severe reduction in the expression of MHC class I and related genes such as β2-microglobulin, Tap1, or Lmp2, but did not affect MHC class II levels. IFN-γ stimulation could not overcome the impaired MHC class I expression in Nlrc5-deficient cells. Upon infection with Listeria monocyogenes, Nlrc5-deficient mice displayed impaired CD8+ T cell activation, accompanied with increased bacterial loads. These findings illustrate critical roles of NLRC5/class I transactivator in MHC class I gene regulation and host defense by CD8+ T cell responses.


  • Open Access

    Intracellular Invasion of Orientia tsutsugamushi Activates Inflammasome in ASC-Dependent Manner

    by Jung-Eun Koo, Hye-Jin Hong, Andrea Dearth, Koichi S. Kobayashi, Young-Sang Koh

    Orientia tsutsugamushi, a causative agent of scrub typhus, is an obligate intracellular bacterium, which escapes from the endo/phagosome and replicates in the host cytoplasm. O. tsutsugamushi infection induces production of pro-inflammatory mediators including interleukin-1β (IL-1β), which is secreted mainly from macrophages upon cytosolic stimuli by activating cysteine protease caspase-1 within a complex called the inflammasome, and is a key player in initiating and maintaining the inflammatory response. However, the mechanism for IL-1β maturation upon O. tsutsugamushi infection has not been identified. In this study, we show that IL-1 receptor signaling is required for efficient host protection from O. tsutsugamushi infection. Live Orientia, but not heat- or UV-inactivated Orientia, activates the inflammasome through active bacterial uptake and endo/phagosomal maturation. Furthermore, Orientia-stimulated secretion of IL-1β and activation of caspase-1 are ASC- and caspase-1- dependent since IL-1β production was impaired in Asc- and caspase-1-deficient macrophages but not in Nlrp3-, Nlrc4- and Aim2-deficient macrophages. Therefore, live O. tsutsugamushi triggers ASC inflammasome activation leading to IL-1β production, which is a critical innate immune response for effective host defense.


  • NLRC5: a newly discovered MHC class I transactivator (CITA)

    by Torsten B. Meissner, Amy Li, Koichi S. Kobayashi


  • NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression

    by Torsten B. Meissner, Yuen-Joyce Liu, Kyoung-Hee Lee, Amy Li, Amlan Biswas, Marja C J A van Eggermond, Peter J. van Den Elsen, Koichi S. Kobayashi

    Tight regulation of MHC class I gene expression is critical for CD8 T cell activation and host adaptive-immune responses. The promoters of MHC class I genes contain a well-conserved core module, the W/S-X-Y motif, which assembles a nucleoprotein complex termed MHC enhanceosome. A member of the nucleotide-binding domain, leucine-rich repeat (NLR) protein family, NLRC5, is a newly identified transcriptional regulator of MHC class I genes. NLRC5 associates with and transactivates the proximal promoters of MHC class I genes, although the molecular mechanism of transactivation has not been understood. In this article, we show that NLRC5-mediated MHC class I gene induction requires the W/S and X1, X2 cis-regulatory elements. The transcription factors RFX5, RFXAP, and RFXANK/B, which compose the RFX protein complex and associate with the X1 box, cooperate with NLRC5 for MHC class I expression. Coimmunoprecipitation experiments revealed that NLRC5 specifically interacts with the RFX subunit RFXANK/B via its ankyrin repeats. In addition, we show that NLRC5 can cooperate with ATF1 and the transcriptional coactivators CBP/p300 and general control nonderepressible 5, which display histone acetyltransferase activity. Taken together, our data suggest that NLRC5 participates in an MHC class I-specific enhanceosome, which assembles on the conserved W/S-X-Y core module of the MHC class I proximal promoters, including the RFX factor components and CREB/ATF1 family transcription factors, to promote MHC class I gene expression.


  • The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity

    by Torsten B. Meissner, Amy Li, Yuen-Joyce Liu, Etienne Gagnon, Koichi S. Kobayashi


  • Open Access

    Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell‐mediated immunity and host resistance to Toxoplasma gondii

    by Braulia C. Caetano, Amlan Biswas, Djalma S. Lima‐Junior, Luciana Benevides, Tiago W. P. Mineo, Catarina V. Horta, Kyoung‐Hee Lee, Joao S. Silva, Ricardo T. Gazzinelli, Dario S. Zamboni, et al.

    Nod2 belongs to the nucleotide‐binding domain leucine‐rich repeat family of proteins and senses bacterial cell wall components to initiate innate immune responses against various pathogens. Recently, it has been reported that T‐cell‐intrinsic expression of Nod2 promotes host defense against Toxoplasma gondii infection by inducing type 1 immunity. Here, we present results that demonstrate that Nod2 does not play a role in the defense against T. gondii infection. Nod2‐deficient mice were fully capable of inducing Th1 immune responses and did not show enhanced susceptibility to infection. Upon TCR stimulation in vitro, Nod2‐deficient CD4+ T cells showed normal activation, IL‐2 production, proliferation, and Th1/2 differentiation. Nod2 mRNA and protein were expressed in CD4+ T and CD8+ T cells at substantial levels. Therefore, Nod2, although expressed in CD4+ T cells, does not have an intrinsic function in T‐cell activation and differentiation.


  • Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy

    by Chikako Ogawa, Yuen-Joyce Liu, Koichi S. Kobayashi

    Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. It was first identified in bacterial cell wall peptidoglycan as an active component in Freunds complete adjuvant. In the cell, MDP is detected by NOD2, a cytoplasmic receptor belonging to the human innate immune system. NOD2 mutations are frequently observed in patients with Crohns disease, an autoimmune disorder, suggesting the significance of the MDP-NOD2 pathway in activating immunity. For this reason, structural modifications of MDP and its derivatives have been extensively studied in an attempt to increase adjuvant activity and boost the immune response effectively for clinical use in the treatment of cancer and other diseases. This review summarizes the synthetic chemistry of MDP and its derivatives and discusses their pharmacological action and stereoselective synthesis.


  • Nod2: a key regulator linking microbiota to intestinal mucosal immunity

    by Amlan Biswas, Tanja Petnicki-Ocwieja, Koichi S. Kobayashi

    The human intestine harbors a large number of bacteria that are constantly interacting with the intestinal immune system, eliciting non-pathological basal level immune responses. Increasing evidence points to dysbiosis of microbiota in the intestine as an underlying factor in inflammatory bowel disease susceptibility. Loss-of-function mutations in NOD2 are among the stronger genetic factors linked to ileal Crohn’s disease. Indeed, Nod2 is a key regulator of microbiota in the intestine, as microflora in the terminal ileum is dysregulated in Nod2-deficient mice. Nod2 is highly expressed in Paneth cells, which are responsible for the regulation of ileal microflora by anti-microbial compounds, and Nod2-deficient ileal intestinal epithelia are unable to kill bacteria efficiently. It is therefore likely that NOD2 mutations in Crohn’s disease may increase disease susceptibility by altering interactions between ileal microbiota and mucosal immunity.


  • Open Access

    A Novel Aminosaccharide Compound Blocks Immune Responses by Toll-like Receptors and Nucleotide-binding Domain, Leucine-rich Repeat Proteins

    by Kyoung-Hee Lee, Yuen-Joyce Liu, Amlan Biswas, Chikako Ogawa, Koichi S. Kobayashi


  • Open Access

    Negative regulation of Toll‐like receptor signaling plays an essential role in homeostasis of the intestine

    by Amlan Biswas, Jeanette Wilmanski, Huamei Forsman, Tomas Hrncir, Liming Hao, Helena Tlaskalova‐Hogenova, Koichi S. Kobayashi

    A healthy intestinal tract is characterized by controlled homeostasis due to the balanced interaction between commensal bacteria and the host mucosal immune system. Human and animal model studies have supported the hypothesis that breakdown of this homeostasis may underlie the pathogenesis of inflammatory bowel diseases. However, it is not well understood how intestinal microflora stimulate the intestinal mucosal immune system and how such activation is regulated. Using a spontaneous, commensal bacteria‐dependent colitis model in IL‐10‐deficient mice, we investigated the role of TLR and their negative regulation in intestinal homeostasis. In addition to IL‐10−/−MyD88−/− mice, IL‐10−/−TLR4−/− mice exhibited reduced colitis compared to IL‐10−/− mice, indicating that TLR4 signaling plays an important role in inducing colitis. Interestingly, the expression of IRAK‐M, a negative regulator of TLR signaling, is dependent on intestinal commensal flora, as IRAK‐M expression was reduced in mice re‐derived into a germ‐free environment, and introduction of commensal bacteria into germ‐free mice induced IRAK‐M expression. IL‐10−/−IRAK‐M−/− mice exhibited exacerbated colitis with increased inflammatory cytokine gene expression. Therefore, this study indicates that intestinal microflora stimulate the colitogenic immune system through TLR and negative regulation of TLR signaling is essential in maintaining intestinal homeostasis.